MedPath

Gyongyi Szabo

🇦🇹Austria
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

A Pilot, Dose Escalating Study on VLX103 in Moderate Alcoholic Steatohepatitis

Phase 1
Withdrawn
Conditions
Hepatic Steatosis
Interventions
First Posted Date
2017-06-28
Last Posted Date
2018-05-30
Lead Sponsor
Gyongyi Szabo
Registration Number
NCT03201159
Locations
🇺🇸

UMass Medical School, Worcester, Massachusetts, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.